Waldemar Gonsiorek - Concepedia

Concepedia

Author

Waldemar Gonsiorek

Inflammation Research Foundation

Also Known As

W Gonsiorek, W. Gonsiorek, WALDEMAR GONSIOREK, Waldemar Gonsiorek

35

Publications

2.5K

Citations

20

H-Index

49

Concepts

All Affiliations

Inflammation Research Foundation AGCO (United Kingdom)Icahn School of Medicine at Mount Sinai Centre for Inflammation Research

WG

About

Waldemar Gonsiorek is an author at Inflammation Research Foundation specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.3K
2	Natural Sciences	4	4	459
3	Allergy	3	3	450
4	Engineering	1	1	15
5	Allergy Medicine	1	1	58

Waldemar Gonsiorek

×

28

Publications

2.5K

Citations

19

H-Index

	Year	Citations
Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide Waldemar Gonsiorek, Charles A. Lunn, Xuedong Fan, Molecular Pharmacology	2000	369
Cloning and characterization of a novel human histamine receptor. Morse Kl, Jiang Behan, Laz Tm, PubMed Molecular PharmacologyMolecular PhysiologySignal TransductionProtein ExpressionG Protein-coupled Receptor	2001	271
Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1 Julie Strizki, Cécile Tremblay, Serena Xu, Antimicrobial Agents and Chemotherapy Antiviral CompoundNeurovirologyMedicineImmunologyAntiviral Response	2005	214
Murine CXCR1 Is a Functional Receptor for GCP-2/CXCL6 and Interleukin-8/CXCL8 Xuedong Fan, Andriani C. Patera, Amy Pong-Kennedy, Journal of Biological Chemistry InflammationCytokineMolecular ImmunologyMurine Cxcr1Functional Interleuin-8	2006	204
Cloning and Characterization of a Novel Human Histamine Receptor Kelley L. Morse, Jiang Behan, Thomas M. Laz, Journal of Pharmacology and Experimental Therapeutics Molecular PharmacologyMolecular PhysiologyAllergyMedicineReceptor (Biochemistry)	2001	188
A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo Charles A. Lunn, Jay S. Fine, Alberto Rojas-Triana, Journal of Pharmacology and Experimental Therapeutics	2006	140
A Novel, Orally Active CXCR1/2 Receptor Antagonist, Sch527123, Inhibits Neutrophil Recruitment, Mucus Production, and Goblet Cell Hyperplasia in Animal Models of Pulmonary Inflammation Richard W. Chapman, Michael Minnicozzi, Chander Celly, Journal of Pharmacology and Experimental Therapeutics	2007	140
Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist Waldemar Gonsiorek, Xuedong Fan, David Hesk, Journal of Pharmacology and Experimental Therapeutics	2007	127
Human Interferon-Inducible 10-kDa Protein and Human Interferon-Inducible T Cell α Chemoattractant Are Allotopic Ligands for Human CXCR3: Differential Binding to Receptor States Mary Ann Cox, Chung‐Her Jenh, Waldemar Gonsiorek, Molecular Pharmacology	2001	127
Discovery of 2-Hydroxy-<i>N</i>,<i>N</i>-dimethyl-3-{2-[[(<i>R</i>)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist Michael P. Dwyer, Younong Yu, Jianping Chao, Journal of Medicinal Chemistry Pharmaceutical ScienceDrug TargetImmunologyPharmacotherapyLead Cyclobutenedione 3	2006	113

Page 1